Form 4: Hims & Hers CMO Reports Routine Stock Transactions

Hims & Hers Health, Inc. Chief Medical Officer Patrick Harrison Carroll reported routine transactions involving Class A Common Stock and Restricted Stock Units, including acquisitions and dispositions for tax obligations.

Summary

• Patrick Harrison Carroll, Chief Medical Officer and Director of Hims & Hers Health, Inc., reported transactions on September 15, 2025.
• Acquired 16,521 shares of Class A Common Stock through the exercise/conversion of derivative securities, increasing beneficial ownership to 186,461 shares.
• Disposed of 6,500 shares of Class A Common Stock at a price of $53.96 per share to cover tax withholding obligations related to RSU vesting and settlement, resulting in 179,961 shares beneficially owned.
• Exercised/converted 8,148 Restricted Stock Units (RSUs) into Class A Common Stock, with 40,744 RSUs remaining beneficially owned.
• Exercised/converted 4,840 Restricted Stock Units (RSUs) into Class A Common Stock, with 48,396 RSUs remaining beneficially owned.
• Exercised/converted 3,533 Restricted Stock Units (RSUs) into Class A Common Stock, with 49,463 RSUs remaining beneficially owned.
• The RSUs represent a contingent right to receive one share of Class A Common Stock for each unit.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to executive compensation (RSU vesting and tax withholding). It contains no new strategic or operational information that would significantly alter the company's outlook, thus maintaining a neutral sentiment.

Positives

• The vesting and conversion of Restricted Stock Units indicate continued executive compensation and alignment of management interests with shareholders.
• The Chief Medical Officer's ongoing beneficial ownership of 179,961 Class A Common Stock shares and a significant number of RSUs (totaling 138,599 across various grants) demonstrates a sustained stake in the company's performance.

Negatives

• The disposition of 6,500 shares was solely for tax withholding obligations, which is a standard practice and not indicative of a negative outlook on the company.

Future Outlook

The remaining Restricted Stock Units are subject to service-based vesting requirements, with various grants vesting in substantially equal quarterly installments over a 4-year period, continuing on specified dates such as March 15, June 15, September 15, and December 15.

Industry Context

This Form 4 filing details routine insider transactions for an executive at Hims & Hers Health, Inc., a telehealth platform. Such filings are standard disclosures and do not typically reflect broader industry trends but rather individual executive compensation and ownership activities.

Stakeholder Impact

• Shareholders: The transactions reflect ongoing executive ownership and compensation, aligning management interests with shareholder value, but do not introduce new material information.
• Employees: The RSU vesting process is a standard component of executive compensation, indicating stability in leadership compensation structures.

Next Steps

• Continued vesting of remaining Restricted Stock Units according to their respective service-based schedules.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions, specifically the vesting of Restricted Stock Units and the disposition of shares to cover tax obligations. It does not provide new material information regarding the company's financial performance, strategic direction, or operational outlook that would warrant a change in investment recommendation. The continued ownership by a key executive is a neutral to slightly positive signal of alignment, but insufficient to drive a 'buy' or 'sell' decision based solely on this filing.

Keywords

Hims & Hers Health, HIMS, Form 4, Insider Transaction, Restricted Stock Units, RSU, Executive Compensation, Stock Ownership, Chief Medical Officer